Pathogenesis and current therapies for non-infectious uveitis.

Area of Science:

• Ophthalmology
• Immunology

Background:

• Non-infectious uveitis (NIU) is an inflammatory eye condition affecting working-age adults.
• Accurate diagnosis is essential for effective NIU management.
• Current treatments include corticosteroids, but chronic cases may require frequent interventions.

Purpose of the Study:

• To review current and emerging therapeutic strategies for non-infectious uveitis.
• To highlight advancements in drug delivery and targeted therapies.
• To emphasize personalized treatment approaches for NIU.

Main Methods:

• Review of existing literature on non-infectious uveitis treatments.
• Discussion of corticosteroids, immunosuppressants (calcineurin inhibitors, antimetabolites), and biologics.
• Exploration of novel intraocular drug delivery systems.

Main Results:

• Corticosteroids remain a primary treatment but have limitations for chronic NIU.
• Immunosuppressants and biologics offer targeted options for refractory cases.
• New drug delivery systems aim for sustained intraocular therapeutic levels.

Conclusions:

• Personalized management of NIU is crucial, considering treatment response and side effects.
• Advancements in immunosuppressants, biologics, and drug delivery enhance NIU treatment.
• Optimizing therapy improves vision, reduces inflammation, and prevents relapses in NIU patients.